P De Meyts
Overview
Explore the profile of P De Meyts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Duyvenvoorde H, van Doorn J, Koenig J, Gauguin L, Oostdijk W, Wade J, et al.
Growth Horm IGF Res
. 2011 Jan;
21(1):44-50.
PMID: 21237682
Objective: While in previous studies heterozygosity for an Insulin-Like Growth Factor 1 (IGF1) defect only modestly decreased height and head circumference, we recently reported on two siblings with severe short...
2.
Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene
van Duyvenvoorde H, van Setten P, Walenkamp M, van Doorn J, Koenig J, Gauguin L, et al.
J Clin Endocrinol Metab
. 2010 Jul;
95(11):E363-7.
PMID: 20668042
Context: Homozygous IGF1 deletions or mutations lead to severe short stature, deafness, microcephaly, and mental retardation. Heterozygosity for an IGF-I defect may modestly decrease height and head circumference. Objective: The...
3.
Wolkenhauer O, Fell D, De Meyts P, Bluthgen N, Herzel H, Le Novere N, et al.
IET Syst Biol
. 2009 May;
3(3):131-6.
PMID: 19449974
The following report selects and summarises some of the conclusions and recommendations generated throughout a series of workshops and discussions that have lead to the publication of the Science Policy...
4.
De Meyts P
Rev Med Liege
. 2005 Jul;
60(5-6):286-90.
PMID: 16035282
About 35 years after the first in vitro studies of the insulin receptor, considerable progress has been accomplished in the structural biology of the insulin-receptor interaction, and of the receptor...
5.
6.
Gray S, Stenfeldt Mathiasen I, De Meyts P
Horm Metab Res
. 2004 Jan;
35(11-12):857-71.
PMID: 14710369
There is compelling evidence from epidemiological studies in humans, as well as in vitro and in vivo experimental observations including transgenic animal models, for a role of the IGF/insulin signalling...
7.
Schmidt A, Chakravarty A, Brommer E, Fenne B, Siebler T, De Meyts P, et al.
Clin Endocrinol (Oxf)
. 2002 Aug;
57(2):293-9.
PMID: 12153610
Seckel syndrome is an autosomal-recessive disorder with a frequency of less than 1/10 000 births in which there are multiple malformations including severe short stature. We report on a patient...
8.
Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, et al.
Diabetologia
. 2002 Jul;
45(5):657-67.
PMID: 12107746
Aims/hypothesis: We examined the properties of a mutant insulin receptor (IR) with an Arg(252) to Cys (IR(R252C)) substitution in the alpha-subunit originally identified in a patient with extreme insulin resistance...
9.
Geddes S, Holst P, Grotzinger J, Gill R, Nugent P, De Meyts P, et al.
Protein Eng
. 2001 Apr;
14(1):61-5.
PMID: 11287679
The structure and biological activities of two disulphide isomers of a C-region deletion mutant of insulin-like growth factor-I (IGF-I) which has an Asn--Gly link engineered at the junction of the...
10.
Vorwerk P, Christoffersen C, Muller J, Vestergaard H, Pedersen O, De Meyts P
Horm Res
. 2000 Jun;
52(5):211-20.
PMID: 10844410
The insulin receptor (IR) in two brothers with a rare syndrome of congenital muscle fiber type disproportion myopathy (CFTDM) associated with diabetes and severe insulin resistance was studied. By direct...